37 citations
,
September 2018 in “The Journal of Clinical Endocrinology and Metabolism”
Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.
The user plans to switch from minoxidil to finasteride or dutasteride for hair loss, while managing hormones with aromataseinhibitors and SHBG blockers. They seek advice on the best options for these treatments, considering past side effects and future therapies.
The user is experiencing reduced hair shedding and increased hair density after using finasteride, minoxidil, derma rolling, granactive retinoid, and Nizoral, while also taking testosterone and aromataseinhibitors. They question if they are a hyper responder to the treatments, despite mixed feedback from others about visible progress.
Finasteride increased testosterone and estrogen, stopped hair loss, and promoted regrowth. Users discussed side effects like libido changes and considered adding minoxidil and aromataseinhibitors.
A user who has tried multiple treatments for hair loss, including oral and topical finasteride and liposomal finasteride, but experienced severe side effects in each case; the user is considering trying RU58841 or aromatiseinhibitors as alternatives.
Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgenetic alopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.